US-based Agilent Technologies has signed a definitive agreement to acquire privately-owned biotechnology company ACEA Biosciences for $250 million in cash.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
Very Good Story